Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2016: 1.000
Source Normalized Impact per Paper (SNIP) 2016: 1.112

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 46, Issue 9 (Sep 2008)

Issues

Allantoin as a marker of oxidative stress in human erythrocytes

Roman Kand'ár
  • 1Department of Biological and Biochemical Sciences, Faculty of Chemical Technology, University of Pardubice, Pardubice, Czech Republic
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Pavla Žáková
  • 2Department of Biological and Biochemical Sciences, Faculty of Chemical Technology, University of Pardubice, Pardubice, Czech Republic
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2008-07-17 | DOI: https://doi.org/10.1515/CCLM.2008.244

Abstract

Background: Uric acid is the final product of purine metabolism in humans. It was determined that this compound has important antioxidative properties and it may be oxidized to allantoin by various reactive oxygen species. Therefore, the measurement of allantoin may be useful for the determination of oxidative stress in humans.

Methods: We measured allantoin and uric acid in human plasma and erythrocytes obtained from patients with chronic renal failure before hemodialysis (n=30) and blood donors (n=30). We used a method based on selective isolation of allantoin from deproteinized plasma and erythrocyte lysate samples on AG 1-X8 resin and its derivatization to glyoxylate-2, 4-dinitrophenylhydrazone. Separation of glyoxylate-2, 4-dinitrophenylhydrazone from interfering substances was achieved on reversed phase HPLC with gradient elution and UV/VIS detection at 360 nm. Uric acid was determined by reversed phase HPLC with UV/VIS detection at 292 nm.

Results: We found significant differences in allantoin and uric acid concentration between the patients with chronic renal failure and the control group both in plasma (20.5±6.5 μmol/L and 323.9±62.9 μmol/L vs. 2.1±1.1 μmol/L and 270.1±62.3 μmol/L, p<0.05) and erythrocytes [82.8±39.1 nmol/g hemoglobin (Hb) and 110.7±28.8 nmol/g Hb vs. 20.1±6.1 nmol/g Hb and 82.1±23.7 nmol/g Hb, p<0.05].

Conclusions: Significant higher levels of allantoin in both plasma and erythrocytes of patients with chronic renal failure indicate that allantoin may be used as a good marker of oxidative stress.

Clin Chem Lab Med 2008;46:1270–4.

Keywords: allantoin; antioxidants; human erythrocytes; oxidative stress; uric acid

About the article

Corresponding author: Mgr. Roman Kand'ár, PhD, Department of Biological and Biochemical Sciences, Faculty of Chemical Technology, University of Pardubice, Strossova 239, 530 03 Pardubice, Czech Republic Phone: +420-466037715, Fax: +420-466037068,


Received: 2008-01-21

Accepted: 2008-04-21

Published Online: 2008-07-17

Published in Print: 2008-09-01


Citation Information: Clinical Chemistry and Laboratory Medicine, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2008.244.

Export Citation

©2008 by Walter de Gruyter Berlin New York. Copyright Clearance Center

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Derrick R. Samuelson, Judd E. Shellito, Vincent J. Maffei, Eric D. Tague, Shawn R. Campagna, Eugene E. Blanchard, Meng Luo, Christopher M. Taylor, Martin J. J. Ronis, Patricia E. Molina, David A. Welsh, and Dana J. Philpott
PLOS Pathogens, 2017, Volume 13, Number 6, Page e1006426
[2]
Zhenyu Li, Aiping Li, Jining Gao, Hong Li, and Xuemei Qin
Frontiers in Pharmacology, 2016, Volume 7
[3]
Oguz Elmas, Onur Elmas, Yakup Aliciguzel, and Tayyup Simsek
Journal of Obstetrics and Gynaecology, 2016, Volume 36, Number 1, Page 34
[4]
Ijeoma Esiaba, Danilyn M. Angeles, Megan S. Holden, John B. C. Tan, Yayesh Asmerom, Gerald Gollin, and Danilo S. Boskovic
Translational Stroke Research, 2016, Volume 7, Number 2, Page 97
[5]
Jingping Liu, Dan Wang, Younan Chen, Hongjie Sun, Sirong He, Chengshi Wang, Guang Yang, Meimei Shi, Jie Zhang, Yan Ren, Li Wang, Yanrong Lu, and Jingqiu Cheng
Molecular BioSystems, 2013, Volume 9, Number 11, Page 2645
[6]
Peng Wang, Chui-Hua Kong, Bei Sun, and Xiao-Hua Xu
Journal of Agricultural and Food Chemistry, 2012, Volume 60, Number 11, Page 2793
[7]
Jiekun Xuan, Guihua Pan, Yunping Qiu, Lun Yang, Mingming Su, Yumin Liu, Jian Chen, Guoyin Feng, Yiru Fang, Wei Jia, Qinghe Xing, and Lin He
Journal of Proteome Research, 2011, Volume 10, Number 12, Page 5433
[8]
Takafumi Toyohara, Yasutoshi Akiyama, Takehiro Suzuki, Yoichi Takeuchi, Eikan Mishima, Masayuki Tanemoto, Ayako Momose, Naoko Toki, Hiroshi Sato, Masaaki Nakayama, Atsushi Hozawa, Ichiro Tsuji, Sadayoshi Ito, Tomoyoshi Soga, and Takaaki Abe
Hypertension Research, 2010, Volume 33, Number 9, Page 944

Comments (0)

Please log in or register to comment.
Log in